FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

883051000168103: daclizumab (AU substance)

Status: current, Primitive. Date: 31-Mar 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1801441000168114 daclizumab (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1801451000168111 daclizumab en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
daclizumab Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
daclizumab has intended active ingredient True daclizumab Inferred relationship Some 1
Zinbryta 150 mg/mL injection, syringe has intended active ingredient True daclizumab Inferred relationship Some 995179038
Zinbryta 150 mg/mL injection, syringe has Australian BoSS True daclizumab Inferred relationship Some 995179038
Zinbryta 150 mg/mL injection, pen device has Australian BoSS True daclizumab Inferred relationship Some 911387106
Zinbryta 150 mg/mL injection, pen device has intended active ingredient True daclizumab Inferred relationship Some 911387106
daclizumab 150 mg/mL injection, pen device has Australian BoSS True daclizumab Inferred relationship Some 406121058
daclizumab 150 mg/mL injection, pen device has intended active ingredient True daclizumab Inferred relationship Some 406121058
daclizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) has Australian BoSS True daclizumab Inferred relationship Some 1997018046
daclizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) has intended active ingredient True daclizumab Inferred relationship Some 1997018046

This concept is not in any reference sets

Back to Start